SCHEMBL9750810

SCHEMBL9750810

CCC(C)(C)OC(C)(C)C

nearest known ligand 0.50

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.50
TDP1 Q9NUW8 2/20 0.50
ALDH1A1 P00352 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16104229 0.88 TSHR (0.41) TSHRTDP1ALDH1A1
SCHEMBL30636 0.85 TSHR (0.56) TSHRTDP1ALDH1A1
Ethane SCHEMBL872203 0.81 TSHR (0.53) TSHRTDP1ALDH1A1
SCHEMBL22233969 0.81 TSHR (0.53) TSHRTDP1ALDH1A1
SCHEMBL333058 0.81 TSHR (0.53) TSHRTDP1ALDH1A1
SCHEMBL9619269 0.81 TSHR (0.53) TSHRTDP1ALDH1A1
Water SCHEMBL7275620 0.81 TSHR (0.53) TSHRTDP1ALDH1A1
Water SCHEMBL22581155 0.81 TSHR (0.53) TSHRTDP1ALDH1A1
Rubidium SCHEMBL7623316 0.81 TSHR (0.53) TSHRTDP1ALDH1A1
Cesium SCHEMBL7632120 0.81 TSHR (0.53) TSHRTDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11773266-B2 Polymer, molded body, foam, resin composition, and production method for polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-10-03 US disclosed
US-20230129965-A1 HYDROPHILIC AND OLEOPHOBIC POLYMER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-04-27 US disclosed
US-20180030175-A1 POLYMER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-02-01 US disclosed
US-20130149281-A1 ORGANIC COMPOUNDS AND THEIR USES NOVARTIS AG (CH) 2013-06-13 US disclosed
US-8445527-B2 Organic compounds and their uses NOVARTIS AG (CH) 2013-05-21 US disclosed
US-20120231998-A1 ORGANIC COMPOUNDS AND THEIR USES NOVARTIS AG (CH) 2012-09-13 US disclosed
US-8211932-B2 Organic compounds and their uses NOVARTIS AG (CH) 2012-07-03 US disclosed
US-20100331243-A1 ORGANIC COMPOUNDS AND THEIR USES NOVARTIS AG (CH) 2010-12-30 US disclosed
US-7825152-B2 serine protease inhibitors, for the treatment of hepatitis c virus infections NOVARTIS AG (CH) 2010-11-02 US disclosed
US-20100204159-A1 ORGANIC COMPOUNDS AND THEIR USES NOVARTIS AG (CH) 2010-08-12 US disclosed
CN-101100619-B High content environmental protection alcohol ether fuel additive for vehicle JIAZHENG LU 2010-08-11 CN disclosed
CN-100580065-C High content environmental protection alcohol ether fuel for vehicle JIAZHENG LU 2010-01-13 CN disclosed
CN-101100618-A High content environmental protection alcohol ether fuel for vehicle JIAZHENG LU (CN) 2008-01-09 CN disclosed
CN-101100619-A High content environmental protection alcohol ether fuel additive for vehicle JIAZHENG LU (CN) 2008-01-09 CN disclosed
US-20070286842-A1 Organic Compounds and Their Uses NOVARTIS AG (CH) 2007-12-13 US disclosed
EP-0284005-B1 METHOD OF PRODUCTION OF POLYOLEFINS IDEMITSU PETROCHEMICAL CO. LTD. (JP) 1991-12-18 EP disclosed
US-4981930-A POLYMERIZATION CATALYSTS IDEMITSU PETROCHEMICAL COMPANY LIMITED (JP) 1991-01-01 US disclosed
EP-0284005-A2 Method of production of polyolefins IDEMITSU PETROCHEMICAL CO. LTD. (JP) 1988-09-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100331243-A1 ORGANIC COMPOUNDS AND THEIR USES OAT, OTC, AOX1 TSHR 3678/4885TDP1 936/4885ALDH1A1 135/4885
US-20130149281-A1 ORGANIC COMPOUNDS AND THEIR USES OAT, HAVCR2, CPT1A TSHR 4191/4885TDP1 2655/4885ALDH1A1 153/4885
US-20070286842-A1 Organic Compounds and Their Uses OAT, OTC, AOX1 TSHR 3678/4885TDP1 936/4885ALDH1A1 135/4885
US-20100204159-A1 ORGANIC COMPOUNDS AND THEIR USES OAT, OTC, AOX1 TSHR 3678/4885TDP1 936/4885ALDH1A1 135/4885
US-20120231998-A1 ORGANIC COMPOUNDS AND THEIR USES OAT, OTC, AOX1 TSHR 3678/4885TDP1 936/4885ALDH1A1 135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.